These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 6417319)
1. Simultaneous determination of tegafur and 5-fluorouracil in serum by GLC using nitrogen-sensitive detection. Kawabata N; Sugiyama S; Kuwamura T; Odaka Y; Satoh T J Pharm Sci; 1983 Oct; 72(10):1162-5. PubMed ID: 6417319 [TBL] [Abstract][Full Text] [Related]
2. Sensitive MS/MS-liquid chromatography assay for simultaneous determination of tegafur, 5-fluorouracil and 5-fluorodihydrouracil in plasma. Remaud G; Boisdron-Celle M; Morel A; Gamelin A J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 824(1-2):153-60. PubMed ID: 16061432 [TBL] [Abstract][Full Text] [Related]
3. Sensitive liquid chromatographic assay for the simultaneous determination of 5-fluorouracil and its prodrug, tegafur, in beagle dog plasma. Chu D; Gu J; Liu W; Paul Fawcett J; Dong Q J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Oct; 795(2):377-82. PubMed ID: 14522043 [TBL] [Abstract][Full Text] [Related]
4. Serum concentrations of 5-FU, ftorafur, and a major serum metabolite following ftorafur chemotherapy. Hornbeck CL; Griffiths JC; Floyd RA; Ginther NC; Byfield JE; Sharp TR Cancer Treat Rep; 1981; 65(1-2):69-72. PubMed ID: 6784923 [TBL] [Abstract][Full Text] [Related]
5. Fluorescence determination of 5-fluorouracil and 1-(tetrahydro-2-furanyl)-5-fluorouracil in blood serum by high-performance liquid chromatography. Iwamoto M; Yoshida S; Hirose S J Chromatogr; 1984 Sep; 310(1):151-7. PubMed ID: 6438145 [TBL] [Abstract][Full Text] [Related]
6. Quantitative gas-liquid chromatographic determination of ftorafur and 5-fluorouracil in biological specimens. Pantarotto C; Fanelli R; Filippeschi S; Facchinetti T; Spreafico F; Salmona M Anal Biochem; 1979 Sep; 97(2):232-8. PubMed ID: 393130 [No Abstract] [Full Text] [Related]
7. Determination of S-1 (combined drug of tegafur, 5-chloro-2,4-dihydroxypyridine and potassium oxonate) and 5-fluorouracil in human plasma and urine using high-performance liquid chromatography and gas chromatography-negative ion chemical ionization mass spectrometry. Matsushima E; Yoshida K; Kitamura R; Yoshida K J Chromatogr B Biomed Sci Appl; 1997 Mar; 691(1):95-104. PubMed ID: 9140762 [TBL] [Abstract][Full Text] [Related]
8. Development and utilization of a combined LC-UV and LC-MS/MS method for the simultaneous analysis of tegafur and 5-fluorouracil in human plasma to support a phase I clinical study of oral UFT®/leucovorin. Peer CJ; McManus TJ; Hurwitz HI; Petros WP J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jun; 898():32-7. PubMed ID: 22565063 [TBL] [Abstract][Full Text] [Related]
10. Improved liquid chromatographic assay for serum fluorouracil concentrations in the presence of ftorafur. Hornbeck CL; Floyd RA; Griffiths JC; Byfield JE J Pharm Sci; 1981 Oct; 70(10):1163-6. PubMed ID: 6795338 [TBL] [Abstract][Full Text] [Related]
11. Determination of 5-fluorouracil and its prodrug tegafur in plasma and tissue by high-performance liquid chromatography in a single injection: validation for application in clinical pharmacokinetic studies. Zufía L; Aldaz A; Castellanos C; Giráldez J Ther Drug Monit; 2003 Apr; 25(2):221-8. PubMed ID: 12657918 [TBL] [Abstract][Full Text] [Related]
12. A protein-bound polysaccharide immunomodulator, PSK, does not suppress the conversion from 1-(2-tetrahydrofuryl)-5-fluorouracil to 5-fluorouracil in patients with gastric cancer. Anai H; Sakaguchi Y; Emi Y; Kohnoe S; Maehara Y; Sugimachi K Anticancer Drugs; 1991 Jun; 2(3):275-8. PubMed ID: 1802023 [TBL] [Abstract][Full Text] [Related]
13. High-performance liquid chromatographic determination of 5-fluorouracil and its prodrugs, tegafur and 4-deoxy-5-fluorouracil, in rat plasma. Jarugula VR; Boudinot FD J Chromatogr B Biomed Appl; 1996 Feb; 677(1):199-203. PubMed ID: 8925097 [TBL] [Abstract][Full Text] [Related]
14. [Sequential changes in blood concentrations of tegafur and 5-FU during oral administration of fine granules of tegafur in patients with primary liver cancer]. Onji M; Yamashita Y; Horiike N; Kanaoka M; Ohta Y; Yoshida T; Hattori M Gan To Kagaku Ryoho; 1982 Mar; 9(3):480-8. PubMed ID: 6307183 [TBL] [Abstract][Full Text] [Related]
15. Relevance of the pharmacology of oral tegafur to its use as a 5-FU pro-drug. Byfield JE; Hornbeck CL; Frankel SS; Sharp TR; Griffiths JC Cancer Treat Rep; 1985 Jun; 69(6):645-52. PubMed ID: 3926308 [TBL] [Abstract][Full Text] [Related]
16. [Serum and tissue concentration of tegafur and 5-FU after administration of tegafur suppository in patients with lung cancer--correcting the influence of residual blood in the tissue]. Ohno K; Nakahara K; Hashimoto J; Matsumura A; Mizuta T; Akashi A; Nakagawa K; Takeda S; Minami M; Kawashima Y Gan To Kagaku Ryoho; 1989 Nov; 16(11):3603-8. PubMed ID: 2510605 [TBL] [Abstract][Full Text] [Related]
17. Determination of tegafur, 5-fluorouracil, gimeracil and oxonic acid in human plasma using liquid chromatography-tandem mass spectrometry. Liu K; Zhong D; Zou H; Chen X J Pharm Biomed Anal; 2010 Aug; 52(4):550-6. PubMed ID: 20138454 [TBL] [Abstract][Full Text] [Related]
18. Simultaneous determination of dihydrofluorouracil and 5-fluorouracil in plasma by high-performance liquid chromatography. Ackland SP; Garg MB; Dunstan RH Anal Biochem; 1997 Mar; 246(1):79-85. PubMed ID: 9056186 [TBL] [Abstract][Full Text] [Related]
19. Hydroxylated metabolies of R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil (Ftorafur) in rats and rabbits. Wu AT; Au JL; Sadée W Cancer Res; 1978 Jan; 38(1):210-4. PubMed ID: 338145 [TBL] [Abstract][Full Text] [Related]
20. Determination of ftorafur and 5-fluorouracil levels in plasma and urine. Wu AT; Schwandt HJ; Finn C; Sadée W Res Commun Chem Pathol Pharmacol; 1976 May; 14(1):89-102. PubMed ID: 935657 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]